Abliva AB (publ) (ABLI.ST)

SEK 0.42

(-0.83%)

Total Debt Summary of Abliva AB (publ)

  • Abliva AB (publ)'s latest annual total debt in 2023 was 424 Thousand SEK , down -20.6% from previous year.
  • Abliva AB (publ)'s latest quarterly total debt in 2024 Q2 was 216 Thousand SEK , down -32.71% from previous quarter.
  • Abliva AB (publ) reported annual total debt of 534 Thousand SEK in 2022, down 0.0% from previous year.
  • Abliva AB (publ) reported annual total debt of - SEK in 2021, down -100.0% from previous year.
  • Abliva AB (publ) reported quarterly total debt of 216 Thousand SEK for 2024 Q2, down -32.71% from previous quarter.
  • Abliva AB (publ) reported quarterly total debt of 424 Thousand SEK for 2023 FY, down -20.6% from previous quarter.

Annual Total Debt Chart of Abliva AB (publ) (2023 - 2007)

Historical Annual Total Debt of Abliva AB (publ) (2023 - 2007)

Year Total Debt Total Debt Growth
2023 424 Thousand SEK -20.6%
2022 534 Thousand SEK 0.0%
2021 - SEK -100.0%
2020 92 Thousand SEK -74.52%
2019 361 Thousand SEK 0.0%
2018 - SEK 0.0%
2017 - SEK 0.0%
2016 - SEK 0.0%
2015 - SEK 0.0%
2014 - SEK 0.0%
2013 - SEK 0.0%
2012 - SEK 0.0%
2011 - SEK 0.0%
2010 - SEK 0.0%
2009 - SEK 0.0%
2008 - SEK 0.0%
2007 - SEK 0.0%

Peer Total Debt Comparison of Abliva AB (publ)

Name Total Debt Total Debt Difference
Alligator Bioscience AB (publ) 16.09 Million SEK 97.366%
Ziccum AB (publ) 857 Thousand SEK 50.525%
Modus Therapeutics Holding AB (publ) - SEK -Infinity%
BioArctic AB (publ) 4.97 Million SEK 91.484%
Sprint Bioscience AB (publ) - SEK -Infinity%
Mendus AB (publ) 24.48 Million SEK 98.269%
Genovis AB (publ.) 79.32 Million SEK 99.465%
Intervacc AB (publ) 181 Thousand SEK -134.254%
QuiaPEG Pharmaceuticals Holding AB (publ) 20.61 Million SEK 97.943%
Active Biotech AB (publ) 3 Million SEK 85.867%
Magle Chemoswed Holding AB (publ) 60.3 Million SEK 99.297%
Bio-Works Technologies AB (publ) - SEK -Infinity%
Aptahem AB (publ) 5 Million SEK 91.52%
Vicore Pharma Holding AB (publ) - SEK -Infinity%
Kancera AB (publ) - SEK -Infinity%
Infant Bacterial Therapeutics AB (publ) - SEK -Infinity%
Fluicell AB (publ) - SEK -Infinity%
Saniona AB (publ) 71.4 Million SEK 99.406%
Lipigon Pharmaceuticals AB (publ) - SEK -Infinity%
Biovica International AB (publ) 7.82 Million SEK 94.584%
Spago Nanomedical AB (publ) - SEK -Infinity%
AcouSort AB (publ) - SEK -Infinity%
Xintela AB (publ) - SEK -Infinity%
Egetis Therapeutics AB (publ) 108.6 Million SEK 99.61%
Karolinska Development AB (publ) 3.07 Million SEK 86.189%
OncoZenge AB (publ) - SEK -Infinity%
Amniotics AB (publ) 2.58 Million SEK 83.566%
2cureX AB (publ) - SEK -Infinity%
CombiGene AB (publ) - SEK -Infinity%
Asarina Pharma AB (publ) 1 Million SEK 57.6%
Calliditas Therapeutics AB (publ) 979.13 Million SEK 99.957%
Camurus AB (publ) 24.5 Million SEK 98.27%
Corline Biomedical AB - SEK -Infinity%
IRLAB Therapeutics AB (publ) 27.56 Million SEK 98.462%
Isofol Medical AB (publ) - SEK -Infinity%
I-Tech AB - SEK -Infinity%
Hansa Biopharma AB (publ) 866.76 Million SEK 99.951%
Cyxone AB (publ) 858 Thousand SEK 50.583%
ExpreS2ion Biotech Holding AB (publ) 1.71 Million SEK 75.219%
Biosergen AB - SEK -Infinity%
Cantargia AB (publ) - SEK -Infinity%
NextCell Pharma AB - SEK -Infinity%
Xspray Pharma AB (publ) 36.8 Million SEK 98.848%
Elicera Therapeutics AB (publ) - SEK -Infinity%
Nanologica AB (publ) 666 Thousand SEK 36.336%
SynAct Pharma AB 637 Thousand SEK 33.438%
Annexin Pharmaceuticals AB (publ) - SEK -Infinity%
Stayble Therapeutics AB (publ) 850 Thousand SEK 50.118%
LIDDS AB (publ) - SEK -Infinity%
Lipum AB (publ) 1.76 Million SEK 75.923%
BioInvent International AB (publ) 23.24 Million SEK 98.176%
Alzinova AB (publ) 800 Thousand SEK 47.0%
Oncopeptides AB (publ) 106.48 Million SEK 99.602%
Pila Pharma AB (publ) 773.08 Thousand SEK 45.154%
Guard Therapeutics International AB (publ) - SEK -Infinity%
Scandinavian ChemoTech AB (publ) - SEK -Infinity%
Simris Alg AB (publ) 90.74 Million SEK 99.533%
Diamyd Medical AB (publ) 30.67 Million SEK 98.618%
Xbrane Biopharma AB (publ) 231.47 Million SEK 99.817%
Ascelia Pharma AB (publ) 1.06 Million SEK 60.038%
Diagonal Bio AB (publ) - SEK -Infinity%